Proven efficacy of the Micronized Purified Flavonoid Fraction (MPFF) on chronic venous edema in the recent Vein Act Program-PRO-C3 study.
In this perspective, an observational study conducted in Russia, 708 Chronic Venous Disease (CVD) patients at C3 CEAP stage were involved to assess the effectiveness of different treatments on edema, CVD symptoms, and quality of life of the patients.
Keep up to date with our content
Subscribe to our newsletter so that you are always up to date with the news.
You can unsubscribe at any time by clicking on the link in our emails.